Libertyville, IL, United States of America

Sheela A Thomas

USPTO Granted Patents = 16 (Patent Applications = 1)

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 5

Average Co-Inventor Count = 7.5

ph-index = 8

Forward Citations = 378(Granted Patents)

Location History:

Vernon Hills, IL (US) (1991 - 1997)
Vernon Hills, IN (1998)
Libertyville, IL (US) (2004 - 2014)

Company Filing History:

14 out of 4,177

Abbott Laboratories Corporation

1 out of 832,680

Other

patents

Years Active: 1991-2014

Loading Chart...

16 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8697736 - 1H-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent PARP inhibitors (2014-04-15),

2. 8217070 - 2-substituted-1H-benzimidazole-4-carboxamides are PARP inhibitors (2012-07-10),

3. 8183250 - Potent PARP inhibitors (2012-05-22),

4. 7999117 - Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors (2011-08-16),

5. 7989656 - Biaryl carboxylic acid apoptosis promoters (2011-08-02),

6. 7754886 - N-acylsulfonamide apoptosis promoters (2010-07-13),

7. 7750004 - Apoptosis promoters (2010-07-06),

8. 7728026 - 2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors (2010-06-01),

9. 7595406 - Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors (2009-09-29),

10. 7504512 - N-acylsulfonamide apoptosis promoters (2009-03-17),

11. 7462724 - Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors (2008-12-09),

12. 6831175 - Kinase inhibitors (2004-12-14),

13. 6720338 - N-acylsulfonamide apoptosis promoters (2004-04-13),

14. 5789591 - Process for preparing 1-substituted (1998-08-04),

15. 5696084 - Amino-lipopetide antifungal agents (1997-12-09),

Title: The Innovative Mind of Sheela A. Thomas: A Leader in PARP Inhibition

Introduction: Sheela A. Thomas, based in Libertyville, IL, is an accomplished inventor renowned for her significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 16 patents, her inventions have made a profound impact on PARP inhibition, offering potential treatments for various diseases and disorders associated with this enzyme.

Latest Patents: Among her latest innovations, Sheela has developed compounds such as 1H-benzimidazole-4-carboxamides that are substituted with phenyl at the 2-position. These compounds serve as potent PARP inhibitors, providing new avenues for treatment. The patents disclose pharmaceutical compositions comprising these compounds, alongside methods for treatment and strategies for inhibiting the PARP enzyme, all aimed at advancing therapy options for critical health issues.

Career Highlights: Throughout her career, Sheela has been associated with prestigious companies such as Abbott Laboratories Corporation and AbbVie Inc., where she has applied her expertise in drug development and innovation. Her work in these organizations reflects her dedication to advancing medical science and enhancing patient care.

Collaborations: Sheela's professional journey is marked by collaborative efforts with esteemed colleagues, including Vincent L. Giranda and Gui-Dong Zhu. These partnerships have fostered innovative research, allowing her to push the boundaries of what's possible in pharmaceutical interventions.

Conclusion: Sheela A. Thomas stands out as a leading inventor in the pharmaceutical sector, with her patents providing critical advancements in PARP inhibition. Her dedication to her work and collaborations has not only contributed to the field but also emphasizes the importance of innovation in tackling complex health challenges.

This text is generated by artificial intelligence and may not be accurate.